Senti Biosciences

Did you know?

Nearly 10% of new cancer cases diagnosed each year in the U.S. are hematologic malignancies, including leukemia, lymphoma and myeloma.

#AML remains a serious blood cancer with significant unmet need, underscoring the importance of continued innovation.

$SNTI

At Senti, our mission is to create a new generation of smarter medicines designed to outsmart complex diseases.

Through innovative Gene Circuit technology, we are advancing novel approaches with the potential to transform patient care.

$SNTI #AML #Leukemia #Oncology

#DidYouSee - BioTuesdays featured our CEO, Timothy Lu!

He discusses how the Company's Gene Circuit platform is advancing next-generation cell and gene therapies.

Read More: bit.ly/4f7zCjo

$SNTI #CellandGeneTherapy #Cancer

#StayInTheLoop

Get the latest updates from Senti Bio delivered straight to your inbox.

Sign up today: bit.ly/3ZVnb39

$SNTI #AML #Leukemia #Oncology

At Senti Bio, we are advancing intelligent Gene Circuits designed for next-generation cell and gene therapies with a focus on oncology.

Guided by our values: Be Bold, Better Together, Build to Last. We are working to tackle hard-to-treat diseases.

$SNTI #Leukemia #AML #Oncology